Lancet Public Health
Feb 2022 Volume 7 Number 2 e93-e194
https://www.thelancet.com/journals/lanpub/issue/current

Articles
The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study
Sébastien Morin, Hannah Barron Moak, Oliver Bubb-Humfryes, Christian von Drehle, Jeffrey V Lazarus,
Esteban Burrone
Non-exclusive voluntary licensing that is access-oriented has been suggested as an option to increase access to medicines to address the COVID-19 pandemic. To date, there has been little research on the effect of licensing, mainly focused on economic and supply chain considerations, and not on the benefits in terms of health outcomes. We aimed to study the economic and health effect of voluntary licensing for medicines for HIV and hepatitis C virus (HCV) in low-income and middle-income countries (LMICs).